One for all—human kidney Caki-1 cells are highly susceptible to infection with corona- and other respiratory viruses

ABSTRACT In vitro investigations of host-virus interactions are reliant on suitable cell and tissue culture models. Results are only as good as the model they are generated in. However, choosing cell models for in vitro work often depends on availability and previous use alone. Despite the vast increase in coronavirus research over the past few years, scientists are still heavily reliant on: non-human, highly heterogeneous or not fully differentiated, or naturally unsusceptible cells requiring overexpression of receptors and other accessory factors. Complex primary or stem cell models are highly representative of human tissues but are expensive and time-consuming to develop and maintain with limited suitability for high-throughput experiments.Using tissue-specific expression patterns, we identified human kidney cells as an ideal target for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and broader coronavirus infection. We show the use of the well-characterized human kidney cell line Caki-1 for infection with three human coronaviruses (hCoVs): Betacoronaviruses SARS-CoV-2 and Middle Eastern respiratory syndrome coronavirus and Alphacoronavirus hCoV 229E. Caki-1 cells show equal or superior susceptibility to all three coronaviruses when compared to other commonly used cell lines for the cultivation of the respective virus. Antibody staining against SARS-CoV-2 N protein shows comparable replication rates. A panel of 26 custom antibodies shows the location of SARS-CoV-2 proteins during replication using immunocytochemistry. In addition, Caki-1 cells were found to be susceptible to two other human respiratory viruses, influenza A virus and respiratory syncytial virus, making them an ideal model for cross-comparison for a broad range of respiratory viruses. IMPORTANCE Cell lines remain the backbone of virus research, but results are only as good as their originating model. Despite increased research into human coronaviruses following the COVID-19 pandemic, researchers continue to rely on suboptimal cell line models of: non-human origin, incomplete differentiation, or lacking active interferon responses. We identified the human kidney Caki-1 cell line as a potential target for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This cell line could be shown to be infectable with a wide range of coronaviruses including common cold virus hCoV-229E, epidemic virus MERS-CoV, and SARS-CoV-2 as well as other important respiratory viruses influenza A virus and respiratory syncytial virus. We could show the localization of 26 SARS-CoV-2 proteins in Caki-1 cells during natural replication and the cells are competent of forming a cellular immune response. Together, this makes Caki-1 cells a unique tool for cross-virus comparison in one cell line. Cell lines remain the backbone of virus research, but results are only as good as their originating model. Despite increased research into human coronaviruses following the COVID-19 pandemic, researchers continue to rely on suboptimal cell line models of: non-human origin, incomplete differentiation, or lacking active interferon responses. We identified the human kidney Caki-1 cell line as a potential target for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This cell line could be shown to be infectable with a wide range of coronaviruses including common cold virus hCoV-229E, epidemic virus MERS-CoV, and SARS-CoV-2 as well as other important respiratory viruses influenza A virus and respiratory syncytial virus. We could show the localization of 26 SARS-CoV-2 proteins in Caki-1 cells during natural replication and the cells are competent of forming a cellular immune response. Together, this makes Caki-1 cells a unique tool for cross-virus comparison in one cell line.

[1]  S. Ciesek,et al.  TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection , 2022, bioRxiv.

[2]  W. Bayer,et al.  Changes in Symptoms Experienced by SARS-CoV-2-Infected Individuals – From the First Wave to the Omicron Variant , 2022, Frontiers in Virology.

[3]  Y. Kamatani,et al.  SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication , 2022, Communications Biology.

[4]  A. Baiker,et al.  Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models , 2022, Virology Journal.

[5]  Zigui Chen,et al.  Profiling of SARS-CoV-2 Subgenomic RNAs in Clinical Specimens , 2022, Microbiology spectrum.

[6]  W. Tan,et al.  Direct Lysis RT-qPCR of SARS-CoV-2 in Cell Culture Supernatant Allows for Fast and Accurate Quantification , 2022, Viruses.

[7]  Y. Nakata,et al.  SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer , 2022, Journal of Biological Chemistry.

[8]  Frances E. Muldoon,et al.  Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity , 2022, Nature.

[9]  H. Zayed,et al.  Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters , 2021, Microbiology spectrum.

[10]  C. Uphoff,et al.  Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies , 2021, PloS one.

[11]  J. Garrido,et al.  SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns , 2021, Frontiers in Immunology.

[12]  Haohao Dong,et al.  Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity , 2021, Nucleic acids research.

[13]  Yong Lin,et al.  The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes , 2021, Cell Discovery.

[14]  P. Shi,et al.  Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses , 2021, Emerging infectious diseases.

[15]  P. Chaudhary,et al.  Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19 , 2021, Cells.

[16]  M. Kane,et al.  Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor , 2021, Cell & bioscience.

[17]  G. Zimmer,et al.  A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets , 2021, bioRxiv.

[18]  D. Qu,et al.  A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry , 2021, Nature Communications.

[19]  D. Robertson,et al.  A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research , 2021, PLoS biology.

[20]  R. Baric,et al.  Comparison of Subgenomic and Total RNA in SARS-CoV-2-Challenged Rhesus Macaques , 2021, Journal of Virology.

[21]  R. Gautier,et al.  A comprehensive library of fluorescent constructs of SARS‐CoV‐2 proteins and their initial characterisation in different cell types , 2020, Biology of the cell.

[22]  D. Lavillette,et al.  The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles , 2020, Journal of Biological Chemistry.

[23]  Silva Kasela,et al.  Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells , 2020, Cell.

[24]  Peter C. DeWeirdt,et al.  Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection , 2020, Cell.

[25]  Francisco J. Sánchez-Rivera,et al.  Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks , 2020, bioRxiv.

[26]  M. Fukushi,et al.  SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant , 2020, Cell Reports.

[27]  L. Guddat,et al.  Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase , 2020, Cell.

[28]  Benjamin J. Polacco,et al.  A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.

[29]  O. Tsang,et al.  Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study , 2020, The Lancet Microbe.

[30]  Natacha S. Ogando,et al.  SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology , 2020, bioRxiv.

[31]  Francisco J. Sánchez-Rivera,et al.  Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks , 2020, Cell.

[32]  Benjamin J Cowling,et al.  Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[33]  Rolf Hilgenfeld,et al.  Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein , 2017, Antiviral Research.

[34]  F. Taguchi,et al.  The contribution of the cytoplasmic retrieval signal of severe acute respiratory syndrome coronavirus to intracellular accumulation of S proteins and incorporation of S protein into virus-like particles. , 2016, The Journal of general virology.

[35]  P. Mayer,et al.  Metabolic role of dipeptidyl peptidase 4 (DPP4) in primary human (pre)adipocytes , 2016, Scientific Reports.

[36]  Mones Abu-Asab,et al.  SARS-Coronavirus Open Reading Frame-9b Suppresses Innate Immunity by Targeting Mitochondria and the MAVS/TRAF3/TRAF6 Signalosome , 2014, The Journal of Immunology.

[37]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[38]  R. Geffers,et al.  Efficient Replication of the Novel Human Betacoronavirus EMC on Primary Human Epithelium Highlights Its Zoonotic Potential , 2013, mBio.

[39]  A. Osterhaus,et al.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.

[40]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[41]  D. Speiser,et al.  Dendritic Cell-Specific Antigen Delivery by Coronavirus Vaccine Vectors Induces Long-Lasting Protective Antiviral and Antitumor Immunity , 2010, mBio.

[42]  Byoung-Hee Lee,et al.  Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43 , 2010, Journal of veterinary science.

[43]  K. Essani,et al.  Differential Susceptibility of Human Cancer Cell Lines to Wild-Type Tanapoxvirus Infection , 2010, The open virology journal.

[44]  John R. Yates,et al.  Severe Acute Respiratory Syndrome Coronavirus Nonstructural Protein 2 Interacts with a Host Protein Complex Involved in Mitochondrial Biogenesis and Intracellular Signaling , 2009, Journal of Virology.

[45]  M. Lenardo,et al.  Molecular Determinants for Subcellular Localization of the Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame 3b Protein , 2009, Journal of Virology.

[46]  J. Li,et al.  The Cytoplasmic Tail of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains a Novel Endoplasmic Reticulum Retrieval Signal That Binds COPI and Promotes Interaction with Membrane Protein , 2006, Journal of Virology.

[47]  Andrew Pekosz,et al.  The ORF7b Protein of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Is Expressed in Virus-Infected Cells and Incorporated into SARS-CoV Particles , 2006, Journal of Virology.

[48]  Wei Lu,et al.  Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release , 2006, Proceedings of the National Academy of Sciences.

[49]  J. Cheng,et al.  Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[50]  L. Enjuanes,et al.  Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein. , 2005, The Journal of general virology.

[51]  Lucy A. Perrone,et al.  Apical Entry and Release of Severe Acute Respiratory Syndrome-Associated Coronavirus in Polarized Calu-3 Lung Epithelial Cells , 2005, Journal of Virology.

[52]  Shengqi Wang,et al.  Subcellular localization and membrane association of SARS-CoV 3a protein , 2005, Virus Research.

[53]  A. Osterhaus,et al.  Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. , 2004, Virus research.

[54]  Y. Guan,et al.  Coronavirus as a possible cause of severe acute respiratory syndrome , 2003, The Lancet.

[55]  P. Collins,et al.  Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. , 2000, Virology.

[56]  J. Melnick,et al.  Defectiveness of Interferon Production and of Rubella Virus Interference in a Line of African Green Monkey Kidney Cells (Vero) , 1968, Journal of virology.

[57]  M. Mayo,et al.  Virus Taxonomy , 1991, Archives of Virology Supplement 10.